162 related articles for article (PubMed ID: 15341340)
1. Drug trend slows in 2003, but higher utilization still driving costs.
Capitation Rates Data; 2004 Jul; 9(7):78-82. PubMed ID: 15341340
[No Abstract] [Full Text] [Related]
2. Can providers survive when accepting pharmacy risk?
Capitation Manag Rep; 1999 Mar; 6(3):33-6. PubMed ID: 10351431
[No Abstract] [Full Text] [Related]
3. Prescription drug benefits: promising solutions.
Goff VV
Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
[TBL] [Abstract][Full Text] [Related]
4. Programs take the edge off pharmacy cost increases.
Capitation Manag Rep; 2002 Apr; 9(4):53-6, 49. PubMed ID: 12004735
[TBL] [Abstract][Full Text] [Related]
5. PBMs' rebate income threatened by lawsuits and move to generics.
Sipkoff M
Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
[No Abstract] [Full Text] [Related]
6. Drugs still influence health costs, but trend abating.
Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
[No Abstract] [Full Text] [Related]
7. Four-dollar generics--increased accessibility, impaired quality assurance.
Choudhry NK; Shrank WH
N Engl J Med; 2010 Nov; 363(20):1885-7. PubMed ID: 21067379
[No Abstract] [Full Text] [Related]
8. Stats & facts. Pharmaceutical utilization contributes to the rise in pharmacy costs.
Manag Care Interface; 2000 Dec; 13(12):52-3. PubMed ID: 11147547
[No Abstract] [Full Text] [Related]
9. Recent economic trends in American pharmacy.
Schondelmeyer SW
Pharm Hist; 2009; 51(3):103-27. PubMed ID: 20527204
[No Abstract] [Full Text] [Related]
10. Generic drug prices still falling.
Barlow RD
Hosp Mater Manage; 1992 Feb; 17(2):1, 12-3. PubMed ID: 10116619
[No Abstract] [Full Text] [Related]
11. Drug utilization still growing, though price increases moderate for common nonspecialty drugs.
Capitation Rates Data; 2007 Aug; 12(8):94-6. PubMed ID: 17703704
[No Abstract] [Full Text] [Related]
12. Pharmaceutical penny-pinching under MinnesotaCare.
Boynton MM
Minn Med; 1994 Jun; 77(6):41-2. PubMed ID: 8041333
[No Abstract] [Full Text] [Related]
13. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
[No Abstract] [Full Text] [Related]
14. Generics lead moderating drug trend, but price spike looms.
Capitation Rates Data; 2006 Jul; 11(7):73-80. PubMed ID: 16944664
[No Abstract] [Full Text] [Related]
15. Generic drug prices said headed up.
Hosp Mater Manage; 1998 May; 23(5):1, 15. PubMed ID: 10179472
[No Abstract] [Full Text] [Related]
16. Think twice before assuming risk for pharmacy costs.
Smith DA
Fam Pract Manag; 1999 Jun; 6(6):17-21. PubMed ID: 10558374
[No Abstract] [Full Text] [Related]
17. Price survey. Generic drug market heats up.
Hosp Mater Manage; 2001 Mar; 26(3):1, 12-3. PubMed ID: 11975141
[No Abstract] [Full Text] [Related]
18. Generic pharmaceutical prices continue their decline in prices from last year.
Hosp Mater Manage; 1996 Feb; 21(2):1, 12-3. PubMed ID: 10154299
[No Abstract] [Full Text] [Related]
19. Facing the next challenge of pharmaceutical care: patient noncompliance.
Bloom DL
Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
[TBL] [Abstract][Full Text] [Related]
20. Valuable information regarding generic drugs. Cutting costs by going generic.
J Am Vet Med Assoc; 2004 Oct; 225(8):1168. PubMed ID: 15521435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
